ABOUT COMPANY :
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
A
holistic objective of dispensing health through a portfolio of injectable
products across various therapeutic segments and delivery systems, has helped
us expand to seven manufacturing facilities in India, with a capacity of
approximately 750 million units. These include four facilities with 22
production lines for finished formulations and three Active Pharmaceutical
Ingredient (API) facilities. Our products are produced at world-class
manufacturing facilities and conform to global compliance, regulatory and
quality specifications.
We are
present in sterile injectables, oncology and ophthalmic segments, and focus on
complex injectables including NCE-1s, First-to-File products and 505(b)(2)
filings. Our products are currently delivered via liquid vials, lyophilized
vials, pre-filled syringes, ampoules, bags and drops; and efforts are underway
to augment additional manufacturing capabilities in complex injectables such as
peptides, long-acting injectables, suspensions and hormonal products. We are
also in the process of including new delivery systems such as pens and
cartridges into our product portfolio.
Our ethos
at work is to consistently focus on meeting diverse injectable needs with
high-quality products at attractive price points. On this strong plinth of
looking ahead, we have successfully and repeatedly harnessed our R&D
expertise in synthesizing complex molecules to produce complex injectables.
Enabling us to develop niche products for diverse markets worldwide.
For more updates
follow
Thank you for visiting my
website, Visit again for
latest pharma updates
No comments:
Post a Comment